Home News and Events Press Release
Press Release
Stay up to date on Argo Biopharma’s latest news and events.
Stay up to date on Argo Biopharma’s latest news and events.
Stay up to date on Argo Biopharma’s latest news and events.
Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a)
Learn MoreArgo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
Learn MoreArgo Biopharma to Present Positive Phase I Results of siRNA Therapeutic BW-20805 for HAE at ACAAI 2025
Learn MoreArgo Biopharma Receives IND Approval from NMPA for Phase II Clinical Trial of siRNA Therapy, BW-40202, for the Treatment of PNH
Learn MoreArgo Biopharma Completes First Patient Dosing for Phase II Clinical Trial in Chronic Hepatitis B
Learn MoreArgo Biopharma Announces Multi-Asset License and Option Agreements with Novartis for Novel Molecules for Cardiovascular Diseases
Learn MoreArgo Biopharma Receives IND Approval for Phase II Clinical Trial of Promising siRNA-PEG-IFNα Combination Therapy in Chronic Hepatitis B
Learn More
为了更好的呈现效果，移动端请竖屏浏览
